Devyser Diagnostics AB (publ) (DVYSR.ST)
SEK 117.0
(0.0%)
SEK 117.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 169.3 Million | 126.61 Million | 93.48 Million | 65.68 Million | 64.3 Million | 48.14 Million |
| Cost of Revenue | 21.2 Million | 20.84 Million | 18.82 Million | 9.04 Million | 12.02 Million | 13.34 Million |
| Gross Profit | 148.1 Million | 105.76 Million | 74.66 Million | 56.64 Million | 52.27 Million | 34.8 Million |
| Operating Expenses | 204.6 Million | 160.71 Million | 96.47 Million | 63.6 Million | 43.62 Million | 38.31 Million |
| Selling, General and Administrative Expenses | 163.5 Million | 132.07 Million | 75.65 Million | 41.9 Million | 33.73 Million | 29.68 Million |
| Research and Development Expenses | 41.1 Million | 28.64 Million | 20.81 Million | 21.7 Million | 9.89 Million | 8.62 Million |
| Other Expenses | - | - | 1.78 Million | 1.77 Million | 1.64 Million | - |
| Cost and Expenses | 225.8 Million | 181.56 Million | 115.29 Million | 72.64 Million | 55.65 Million | 51.65 Million |
| Operating Income | -56.5 Million | -54.94 Million | -21.81 Million | -6.95 Million | 8.64 Million | -3.51 Million |
| Interest Expense | 800 Thousand | 500 Thousand | 939 Thousand | 925 Thousand | 785 Thousand | 596 Thousand |
| Income Tax Expense | -800 Thousand | -6.79 Million | -1.17 Million | -985 Thousand | 2.62 Million | -751 Thousand |
| Earnings before Tax | -54.4 Million | -52.72 Million | -22.28 Million | -10.85 Million | 10.15 Million | -232 Thousand |
| Net Income | -53.6 Million | -45.95 Million | -20.72 Million | -10.91 Million | 7 Million | 519 Thousand |
| Earnings Per Share Basic | -3.31 | -2.89 | -1.85 | -375.94 | 241.52 | 17.88 |
| Earnings Per Share Diluted | -3.31 | -2.89 | -1.85 | -375.94 | 231.01 | 17.28 |
| Weighted Average Shares Outstanding | 16.18 Million | 15.92 Million | 11.23 Million | 29.02 Thousand | 29.02 Thousand | 29.02 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 16.18 Million | 15.92 Million | 11.23 Million | 29.02 Thousand | 30.34 Thousand | 30.03 Thousand |
| Gross Margin | 0.87 | 0.84 | 0.80 | 0.86 | 0.81 | 0.72 |
| EBIT Margin | -0.26 | -0.39 | -0.20 | -0.06 | 0.17 | -0.05 |
| Profit Margin | -0.32 | -0.36 | -0.22 | -0.17 | 0.11 | 0.01 |
| EBITDA | -43.8 Million | -46.02 Million | -18.05 Million | -6.96 Million | 13.26 Million | 1.6 Million |
| Earnings Before Tax Margin | -0.33 | -0.43 | -0.23 | -0.11 | 0.13 | -0.07 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 48.7 Million | 53.2 Million | 50.7 Million | 45.4 Million | 169.3 Million | 46.7 Million |
| Cost of Revenue | 13.5 Million | 10.7 Million | 8.8 Million | 4.3 Million | 21.2 Million | 5.9 Million |
| Gross Profit | 35.2 Million | 42.5 Million | 41.9 Million | 41.1 Million | 148.1 Million | 40.8 Million |
| Operating Expenses | 55.9 Million | 64.7 Million | 57.9 Million | 56.1 Million | 204.6 Million | 47.4 Million |
| Selling, General and Administrative Expenses | 46.8 Million | 49.5 Million | 47.2 Million | 43.8 Million | - | 37.2 Million |
| Research and Development Expenses | 9.1 Million | 15.2 Million | 10.7 Million | 12.3 Million | - | 10.2 Million |
| Other Expenses | -9.1 Million | 900 Thousand | - | - | - | - |
| Cost and Expenses | 69.4 Million | 75.4 Million | 66.7 Million | 60.4 Million | 225.8 Million | 53.3 Million |
| Operating Income | -20.7 Million | -22.2 Million | -16 Million | -15 Million | -56.5 Million | -6.6 Million |
| Interest Expense | 900 Thousand | 900 Thousand | 900 Thousand | -100 Thousand | 800 Thousand | 500 Thousand |
| Income Tax Expense | -300 Thousand | 400 Thousand | 1.2 Million | -3.1 Million | -800 Thousand | 800 Thousand |
| Earnings before Tax | -23.5 Million | -22.6 Million | -10.9 Million | -16.2 Million | -54.4 Million | -5.2 Million |
| Net Income | -23.2 Million | -22.9 Million | -12.2 Million | -13.1 Million | -53.6 Million | -6 Million |
| Earnings Per Share Basic | -1.41 | -1.40 | -0.75 | -0.80 | - | -0.37 |
| Earnings Per Share Diluted | -1.41 | -1.40 | -0.75 | -0.80 | - | -0.37 |
| Weighted Average Shares Outstanding | 16.48 Million | 16.3 Million | 16.28 Million | 16.28 Million | 16.18 Million | 16.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.48 Million | 16.3 Million | 16.28 Million | 16.28 Million | 16.18 Million | 16.16 Million |
| Gross Margin | 0.72 | 0.80 | 0.83 | 0.91 | 0.87 | 0.87 |
| EBIT Margin | -0.47 | -0.31 | -0.21 | -0.26 | - | -0.09 |
| Profit Margin | -0.48 | -0.43 | -0.24 | -0.29 | -0.32 | -0.13 |
| EBITDA | -22.8 Million | -16.6 Million | -10.6 Million | -11.8 Million | - | -4 Million |
| Earnings Before Tax Margin | -0.43 | -0.42 | -0.32 | -0.33 | -0.33 | -0.14 |
1798
3630
2916
ALTX
AVCRF
PSYBF